Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

Morabito F.

;Tripepi G.;Del Poeta G.;Mauro F. R.;Reda G.;Sportoletti P.;Laurenti L.;Coscia M.;Herishanu Y.;Bossio S.;Varettoni M.;Murru R.;Chiarenza A.;Visentin A.;Condoluci A.;Moia R.;Pietrasanta D.;Loseto G.;Consoli U.;Scortechini I.;Rossi F. M.;Zucchetto A.;Al-Janazreh H.;Vigna E.;Martino E. A.;Cassin R.;D'Arrigo G.;Galimberti S.;Rago A.;Angeletti I.;Biagi A.;Del Giudice I.;Bomben R.;Neri A.;Fronza G.;Monti P.;Menichini P.;Olivieri J.;Cutrona G.;Rossi D.;Cuneo A.;Di Raimondo F.;Gaidano G.;Polliack A.;Trentin L.;Foa R.;Ferrarini M.;Gattei V.;Gentile M.

2021-01-01